Innovation Partner
Organon
Website: https://www.organon.com/
Organon (NYSE: OGN) is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets. Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, N.J.
Cloud Services Partners
Hewlett Packard Enterprise - Alpha3 Cloud
Website: https://www.hpe.com/us/en/about/diversity/startups.html
HPE is the global edge-to-cloud company built to transform your business. How? By helping you connect, protect, analyze, and act on all your data and applications wherever they live, from edge to cloud, so you can turn insights into outcomes at the speed required to thrive in today’s complex world. The HPE purpose to advance the way people live and work is exemplified through our HPE Diversity Startup program. This HPE force for good program provides complementary cloud services vouchers and technical consulting to qualified women and minority founded startups with our trusted HPE GreenLake service provider partner, Alpha3 Cloud. Together, HPE and Alpha3 Cloud want to make a positive impact in Women’s Health.
Oncology Partner
GSK
Website: https://www.gsk.com/en-gb/
GSK is committed to maximising patient survival through transformational medicines, with a current focus on breakthroughs in immuno-oncology and tumor-cell targeting therapies, and development in haematologic malignancies, gynaecologic cancers and other solid tumours.
Gynaecologic cancers are among the most common cancers affecting those assigned female at birth, but awareness of these cancers and their symptoms remains low. At GSK, we are committed to supporting continued innovation in gynaecologic cancers, keeping the patient’s voice at the heart of our mission, and building a pipeline of novel programmes to meet their needs. For more information about our work in oncology, please visit: https://www.gsk.com/en-gb/
Knowledge Partner
McKinsey and Company
Website: https://www.mckinsey.com/
There was a time when economic growth, sustainability, and inclusion were seen as trade-offs, but leaders today need to achieve all three. This new paradigm of growth will be more sustainable, driving innovation while reducing environmental impact. It will also be more inclusive, creating access to opportunities for people worldwide.
This is not an easy task, but McKinsey & Company's ambition is to help organizations and their leaders make it a reality. They combine bold strategies and transformative technologies to help organizations innovate more sustainably, achieve lasting gains in performance, and build workforces that will thrive for this generation and the next.
Platinum Partner
Sumitomo Pharma America
Website: https://www.us.sumitomo-pharma.com
Sumitomo Pharma America (SMPA) is focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry & neurology, oncology, urology, women's health, rare disease, and cell & gene therapies. The company's diverse portfolio includes several marketed products and a robust pipeline of early- to late-stage assets. SMPA leverages proprietary in-house advanced analytics and computational technology platforms to accelerate discovery, research, and help bring novel therapies to patients sooner. SMPA is a Sumitomo Pharma Co., Ltd., company. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn.
Deloitte
Website: https://www.deloitte.com
Where impact happens
Throughout the health ecosystem, you’ll find courageous and inspiring people who are committed to driving transformation, advancing health equity, and leading a well-being revolution. Where you find innovators committed to sustainable progress, you’ll find Deloitte’s Life Sciences & Health Care practice. Our leaders work side by side to orchestrate and deliver on the business of science and health. We bring trusted, flexible approaches that can foster innovation, harness new technologies, and formulate consumer-driven strategies to engineer a digitally enabled, equitable future of health—starting today.
Gold Partners
Celanese
Website: https://bit.ly/3a0JriQ
Celanese works closely with you to develop innovative sustained-release dosage forms to help you deliver patient-centric therapies, improved medicine and better healthcare economics. Our VitalDose® EVA copolymer drug-delivery platform is an enabling technology for drug-eluting implants and inserts, with flexibility to address a variety of formulation challenges and tailoring the release rate of your drug.
∙ Compatible with biologics, small molecules, and RNA
∙ Provides reliable local or systemic drug administration
∙ High drug loading capacity (≤ 75%)
∙ Engineered long-acting dosage profiles (zero-order or nonlinear profiles)
∙ Ease of formulation, configurable into a variety of geometries
∙ An established regulatory path with long clinical use history
From FEASIBILITY to DEVELOPMENT to COMMERCIALIZATION
Our scientists and engineers are available from concept to commercialization, providing development services, material supply aligned with GMP principles and regulatory support.
PRIA Healthcare
Website: https://priahealthcare.com/who-we-help/medical-device-manufacturers/
PRIA Healthcare is a full-spectrum reimbursement services firm based in Connecticut. Vital to the successful commercialization of over 100 medical devices since 2012, PRIA Healthcare is an industry-leading partner of innovators in MedTech and Life Science. PRIA’s renowned experts in reimbursement strategy and health care economics provide support to medical device companies by navigating often challenging and otherwise uncertain reimbursement pathways, determining the coding, coverage, and payment for market access and adoption of new technologies. Agnostic to specialty and poised to support the entire product journey of innovations in healthcare from concept through commercialization.
Please visit www.priahealthcare.com to learn more about PRIA's portfolio, including services such as market analysis, reimbursement strategy and planning, and patient access solutions.
PRIA Healthcare - Accelerating healthcare innovation.
UPMC
Website: http://www.upmc.com/
A $26 billion health care provider and insurer, Pittsburgh-based UPMC is inventing new models of patient-centered, cost-effective, accountable care. The largest nongovernmental employer in Pennsylvania, UPMC integrates 95,000 employees, 40 hospitals, 800 doctors’ offices and outpatient sites, and a nearly 4.5 million-member Insurance Services Division, the largest medical insurer in western Pennsylvania. In the most recent fiscal year, UPMC contributed $1.5 billion in benefits to its communities, including more care to the region’s most vulnerable citizens than any other health care institution, and paid more than $900 million in federal, state, and local taxes. Working in close collaboration with the University of Pittsburgh Schools of the Health Sciences, UPMC shares its clinical, managerial, and technological skills worldwide through its innovation and commercialization arm, UPMC Enterprises, and through UPMC International. U.S. News consistently ranks UPMC Presbyterian Shadyside among the nation’s best hospitals in many specialties and ranks UPMC Children’s Hospital of Pittsburgh on its Honor Roll of America’s Best Children’s Hospitals. For more information, go to UPMC.com.
PPD
Website: https://www.ppd.com/
PPD is a leading global contract research organization focused on delivering life-changing therapies. PPD offers proven solutions that incorporate diversity in every stage of the clinical trial ranging from early phase engagement with lactation studies to Phase II-III to pharmacovigilance to peri- and post-approval services and vaccines.
PPD has a deep understanding of the regulatory drivers, treatment landscape, unmet needs and recruitment and retention strategies across the spectrum of women’s health indications. We are committed to deploying solutions needed to mitigate potential challenges in women’s health studies, including competition for women in clinical trials and site resources, and the reluctance of women to participate in these studies. We leverage our broad-based site network, targeted training and communication strategies – all with women in mind.
Clinical Trial Site and Patient Centric Solutions | PPD
EDS Global Capabilities | PPD Inc
Labcorp
Website: https://www.Labcorp.com
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. Learn more about Labcorp at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.
PFG MedComm
Website: https://www.pfgmed.com/
Accomplishing access through value communication. That’s what we do.
PFG MedComm is a woman and minority-owned strategic market access agency that specializes in leveraging value communication to achieve access goals. We’ve transformed the traditional agency model with our unique 360° approach that considers the entire development lifecycle when planning for market access. Our proprietary process involves anticipating challenges, adapting strategic plans, and accomplishing access through seamless execution and field engagement.
As a full-service strategic market access agency, our capabilities run the gamut from the earliest stages of clinical planning and strategy through launch, training and beyond. We are experts in developing end-to-end marketing strategies and tactics across all healthcare stakeholders, (ranging from various types of payers and access decisionmakers to healthcare professionals and patients), with experience in US and international markets across EMEA, LATAM and APAC.
Our team has a broad range of experience to support medical, payer and HEOR communication strategy across pharmaceutical, biotech, medical device, and digital therapeutic companies. Over the past ten years, the PFG MedComm team has supported over 60+ brands (including 33 launches both US and global), across 50+ indications within 20+ therapeutic categories.
We take those complicated ideas and make them understandable to all stakeholders to ensure a company's drugs, therapies, devices, and diagnostics reach those who need them with minimal hurdles.
Ferring Pharmaceuticals
Website: http://www.ferringusa.com/
As a privately-owned, biopharma company, Ferring focuses on developing life-changing innovations that help people live better lives. Grounded in a 70-year commitment to science and research, we are relentless in our pursuit of therapies that help people build families, stay healthy, and fight disease.
We’re committed to being the world-leading, most trusted healthcare company in reproductive medicine and maternal health, and a leader in specialty areas within gastroenterology and orthopaedics. With that ambition in mind, we’re dedicated to following the science, conducting exhaustive research, and going where others may not—which means that people will always come first.
Since launching our U.S. operations in 1980, Ferring continues to sustain record growth, introduce new products, and expand our operations. Today, through our own innovative research and strategic acquisitions, we’re working to achieve today’s ‘firsts:’ unlocking the power of the human microbiome, discovering new, more accessible ways for people to start and build families, and tackling some of the most debilitating diseases and conditions of our time.
For more information, visit www.ferringusa.com
Event Partners
Cedar Health Research Powered by Aspen
Website: https://www.cedarhealthresearch.com/
Cedar Health Research Powered by Aspen
Cedar Health Research is a multi-specialty clinical research site-network based out of Dallas, Texas. They are powered by state-of-the-art AI technology, a world-class network of researchers, and connectivity to more than 1.8 million patients through EHR and LIS database integrations. Cedar Health Research is committed to transforming the clinical research domain through the effective adoption of innovative technologies.
Bowdoin Group
Website: https://www.bowdoingroup.com/
The Bowdoin Group specializes in executive search, focused on placing change-makers and strategic leaders across the innovation economy while supporting additional growth through recruitment process outsourcing (RPO).
Our network covers the Health and Technology industries, placing disruptive leaders who are redefining the landscape of how we live and work.
Within the Health and Technology landscape, the firm’s expertise in Digital Health, Software and Technology, FinTech, Biotech, and Diagnostics inform the service we provide for our clients and partners leading these industries. We continue to build lasting partnerships across the financial sector, building out portfolio companies for top-tier Private Equity and Venture Capital firms.
Restful Pump
Website: https://restfulpump.com/
Founded by a mom for moms, Restful Pump® has engineered the world’s first to market premier forward leaning lactation systems for at home, at work or on the go.
Postpartum women are fatigued, sleep deprived, managing breast pumping positioning, milk supply issues, pain and/or breast tissue complications, and some addressing return to employment. Using a breast pump every 4-5 hours, 24 hours a day doesn’t have to be such an uncomfortable chore.
Now women can rest, sleep, or multitask in a supportive hands-free position, using any type of breast pump. While providing comfort, convenience, productivity, possibly reducing breast tissue complications and increasing pumping durations, our devices may even negate the need for baby formula.
Restful Pump® is solving a global problem with novel Class 1 medical devices. With an MD’s prescription, and possible US reimbursement via health insurance, Restful Pump® products aim to be as medically necessary as a breast pump in the postpartum period.
With over 12 patents filed for over 10 products in 30 countries there is massive potential for safe, high-yield investments with durable medical equipment annual recurring revenue.
Pump While You Sleep®
Sheppard Mullin
Website: https://www.sheppardmullin.com/whlc
Sheppard Mullin’s Women in Healthcare Leadership Collaborative (WHLC) is an exclusive national leadership initiative committed to supporting women professionals in or advancing into leadership positions within the healthcare and life sciences industries.
WHLC was established in response to significant and persistent systemic gender disparities in institutional leadership positions in the healthcare and life sciences industries. Despite constituting a vast majority of the workforce, women continue to hold a small minority of these positions.
Drawing upon Sheppard Mullin’s nationally-ranked healthcare practice, and the law firm’s leadership in diversity and inclusion, WHLC aims to reverse this trend by providing women professionals access to critical resources and networking opportunities designed to support them as they progress in their careers. WHLC hosts regular roundtable discussions focusing on complex legal and business issues and cutting-edge innovation and developments in the healthcare industry, as well as professional skills training and development, and quality networking events connecting these professionals to other leaders in the industry. Sheppard Mullin hosts WHLC events virtually and in various locations across the country.
Fish & Richardson
Website: https://www.fr.com/industries/life-sciences/
Fish & Richardson has represented pioneering life science innovators from our earliest days. We work closely with life sciences companies to help them achieve their strategic IP goals through acquisition, partnering, licensing, financing, and enforcement. We do this by bringing a unique holistic approach to our clients’ IP matters, fostered by the collaboration between our patent prosecution, litigation, and regulatory practices. We have helped our clients build valuable patent portfolios worth billions of dollars, score big victories at the Patent Trial and Appeal Board (PTAB), and win bet-the-company cases in court. When life sciences clients come to Fish to build an IP strategy, they know that we will leave no stone unturned when crafting creative and comprehensive solutions to maximize the value of their IP.
Cambridge Design Partnership
Website: http://www.cambridge-design.com/femtech
Cambridge Design Partnership is an end-to-end innovation partner, propelling global brands and ambitious start-ups to success. We build breakthrough products and services – from insight to ideas, prototypes to production – bringing innovation to life.
We help partners realize the potential of innovation in women’s health by helping accelerate their innovation, and we maintain a laser-sharp focus on user-centered design throughout. We focus on building strategic partnerships that leverage our expert understanding of the landscape and complexities created by years of under-representation.
The result? By putting people and context at the center of our thinking, and applying consumer and healthcare knowledge gathered globally by our multidisciplinary team, we empower partners to create meaningful incremental and transformational innovations that improve lives.
One partner. No barriers. Extraordinary results
Auria Care
Website: https://auria.care/
Auria® is the first at-home biological breast cancer screening test for women. Powered by tears, Auria looks at protein biomarkers involved in the early inflammatory process due to abnormalities in breast tissue. Auria includes a clinical consultation with a breast health specialist to review results, discuss risk, and answer questions. Backed by physicians, clinical trials, and peer-reviewed publications, Auria’s convenient and non-invasive test empowers women on their breast health journey where early detection is the key in the fight against breast cancer. Auria is available for women starting at age 30 and for any size, any shape, dense breasts, implants, all bodies, and all breasts. Auria makes it clear for everyone. Auria is a product of biotech startup Namida Lab, the world leader in developing accessible proteomic cancer screening tools.
Venable LLP
Website: https://www.venable.com/
Venable LLP is an American Lawyer Global 100 law firm headquartered in Washington, DC that serves as primary counsel to a worldwide clientele of large and mid-sized organizations, nonprofits, and high-net-worth entrepreneurs and individuals. With more than 850 professionals across the country, including California, Delaware, Florida, Illinois, Maryland, New York, Virginia, and Washington, DC, the firm strategically advances its clients' objectives in the U.S. and around the globe. Venable advises clients on a broad range of business and regulatory law, legislative affairs, complex litigation, and the full range of intellectual property disciplines. For more information, please visit www.Venable.com.
RemovAid
Website: https://www.removaid.com/
RemovAid - pioneering implant removals
We are a female-founded and led company that has prioritized women's health by creating our first product, the RemovAid™, specifically for Women. It is engineered to remove contraceptive implants. Our technology is easy to use, allows for a broader range of healthcare personnel to provide removal services, and enables healthcare providers to better utilize available resources. In stretched healthcare systems with increasing costs task shifting is of big importance. The RemovAid™ has received CE approval under MDR 2017/745 and is for sale in select markets.
The market for implanted medications and technologies is growing and will play an important role in the future of medicine. Patients who rely on long-term health management through implants often face the challenge of frequent, unpleasant replacements. Our mission is to make implants more accessible through gentle and efficient removals or replacements. By providing innovative removal solutions, we aim to improve patients’ ability to seamlessly integrate these technologies into their everyday lives!
Astellas
Website: https://www.astellas.com/us/
Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the U.S. and around the world.
Presagen
Website: https://www.presagen.com/
Presagen is an AI healthcare company that is changing the way clinics, patients, and medical data from around the world are connected through AI. Its platform, The Social Network for Healthcare, connects clinics and patients globally, and enables collaboration and data sharing to create scalable AI healthcare products that are affordable and accessible for all. The decentralized network democratizes the creation of AI products, promotes collaboration through incentives, and protects data privacy and ownership. With a focus on improving Women’s Health outcomes globally, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for couples struggling with fertility. With a vision of creating the largest network of clinics, patients, and medical data from around the world, Presagen is driving the future of AI Enhanced Healthcare.
Pregnolia
Website: www.pregnolia.com
Pregnolia AG is a Swiss medical technology company in the field of preterm birth detection. The company has developed a CE-marked measurement system to accurately determine the stiffness of the cervix. This parameter is an important indicator for assessing the risk of preterm birth. Early diagnosis of preterm birth enables preventive interventions to prolong pregnancy and improve the health of newborns.
The Pregnolia products are CE certified (Directive 93/42/EEC on Medical Devices) and are for sale in selected markets. Not for sale in the United States.
Watkins-Conti Products Inc
Website: http://www.watkinscontiproducts.com/
Watkins Conti Products, Inc. is a Female founded and owned, Platform Women’s Healthcare company and product design firm that is focused on the creation of innovative and affordable consumer medical devices.
The company’s flagship product is a non-invasive solution for stress incontinence in women. The problem impacts and estimated ONE in THREE women globally. The disruptive, patented product offers multiple recurring revenue streams. Watkins-Conti has additional products in the pipeline to improve the consumer experience, specifically for health related issues that women face that are often seen as shameful or taboo.
Guidea
Website: www.femovate.com
Guidea: Pioneering Digital Health Experiences
Guidea is an industry-leading design partner, delivering experiences that have touched +1B lives worldwide. With an impressive client portfolio including dozens of live products, clinical trials, and FDA approvals, we’re not just designers – we’re creators of transformative solutions. We work as trusted partners to top health companies, leading medical schools, and giants of the pharma world to crystallize the future value and impact of their vision, then research, design and launch the products.Our collaborations consistently deliver meaningful and award-winning improvements for patient outcomes, and raise the standard for digital health care. Our sponsorship program for early stage start-ups, Femovate, embodies our commitment to underrepresented founders and underserved populations.We focus on finding partners we believe in and helping to bring their vision to life. Whether you’re a start
Nurx from Thirty Madison
Nurx by Thirty Madison delivers equitable, affordable access to virtual-first care for women. Nurx is a technology-enabled platform focused on unlocking access to women's specialty care for over 500k patients across the U.S., powered by a medical group comprised of over 100+ licensed specialized providers.
Reprocare
Reprocare is a reproductive justice-guided organization that strives to holistically support people through all stages of abortion care -- as well as reduce economic and racial inequalities in abortion access. Reprocare works toward our mission by building deep partnerships with movement stakeholders and community organizations, and by developing purposeful tools and processes in collaboration with our partners.
We currently offer two platforms to support overburdened communities seeking abortion care, and help people take control of their reproductive health needs:
- Reprocare's Piggybank Funding Platform: Our Funding Platform unifies financial aid requests with abortion funding in one secure application
- Reprocare's Healthline: Our Healthline offers anonymous and peer-based emotional support, medical information, and referrals for people having abortions.
Event & Media Partner
Boston Globe Media
Website: https://www.bostonglobe.com/
Boston Globe Media is a multimedia organization that provides news, entertainment, and commentary across multiple brands and platforms.
Through in-depth reporting and coverage coming straight from the world’s hub of innovation in health, science, and medicine, Boston Globe Media gives brands the opportunity to create meaningful content, align themselves with award-winning journalism, and reach a robust audience of readers keenly focused on advancements in healthcare and beyond. With powerful storytelling, in-depth filmmaking, great advice, interactive local and global events, immersive branded content, and the largest social media following in New England, we go beyond advertising and help brands forge a meaningful connection with the audiences they want to reach. If you want to educate, entertain, or simply introduce your brand to the world, then allow us to reintroduce ourselves. We are Boston Globe Media.
Read, listen and discover more at Globe.com, Boston.com, STAT, Globe Events, and our in-house creative agency, Studio/B.
PR Partner
Matter
Website: https://www.matternow.com
Matter is a Brand Elevation Agency that integrates PR, marketing and creative services into campaigns that inspire action and build value. Founded in 2003, with offices spanning North America, Matter works with the world’s most innovative companies across healthcare, high-technology, consumer technology and consumer markets.
Media Partners
Women of Wearables
Website: https://www.womenofwearables.com/
Please visit our website for more information.Femtech World
Website: https://www.femtechworld.co.uk/
We are a global media platform, run by award winning journalists, on a mission to contribute to closing the gender health gap by providing valuable news, insights and analysis on the exciting femtech sector. Produced by specialist health media group Aspect Publishing, Femtech World aims to give the femtech community a voice, breaking down professional borders, spreading opportunities and destigmatising women’s health issues.
Springboard
Website: https://sb.co
Springboard’s mission is to accelerate the growth of entrepreneurial companies led by women through access to essential resources and a global community of experts. We are a leading network of influencers, investors and innovators dedicated to building high-growth companies led by women who are transforming industries in technology and life science.
World Pharma Today
Website: https://www.worldpharmatoday.com/
Please visit our website for more information.Pharma News HQ
Website: http://pharmanewshq.com/
Pharma News HQ, the journal dedicated to the pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmanewshq.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production
MassMEDIC
Website: http://www.massmedic.com/
Founded in 1996, the Massachusetts Medical Device Industry Council (MassMEDIC) is the largest regional medtech association in the United States, with over 300 members representing manufacturers, product developers, suppliers, research institutions and academic health centers.
For more than a quarter of a century, MassMEDIC has been the voice of the groundbreaking medical technology industry in New England, advocating for sound public policy that supports innovation and fostering a community built on a shared purpose.
As a MassMEDIC member, you are part of a community of innovators that believe in collaboration and collective success. Our network and resources help you navigate today’s evolving healthcare ecosystem and strengthen your goals through connection, education, awareness, and advocacy.
Magee-Womens Research Institute
Website: https://mageewomens.org/
Please visit our website for more information.Endeavor Venture Fund
Website: https://www.gershoncapital.com/our-investments/
Endeavor Venture Funds is an evergreen Swiss Fund, established in 2009, and has invested in groundbreaking companies like Moderna and 69 life science companies, reshaping the healthcare system. Endeavor’s companies are typically later stage Series B in Biotech, Medtech, and Digital Health. They all possess disruptive technologies with strong scalable commercial potential, driven by great entrepreneur/founders who look for coaching and partnerships within our ecosystem to enhance and build their companies into the next great unicorns.
Most importantly, we invest in amazing entrepreneurs with groundbreaking disruptive innovation that we believe will provide the healthcare system with real-world solutions to improve healthcare outcomes and make peoples’ lives better and healthier every day.
